Reframe
PrivateLast Round
Series A
Mar 5, 2022
Est. Valuation
$100M
Total Funding Raised
$26.68M
Company Overview
Reframe operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Series A round in March 2022.
Reframe is a health and wellness company that offers a neuroscience-based mobile application designed to help individuals change their relationship with alcohol through educational content, tracking tools, and community support.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Patient Engagement, Subscription Commerce, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reframe Comparables
Compare Reframe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sunnyside | 89% | |
| Sunflower | 88% | |
| One Year No Beer | 83% |
For institutional investors. Book with your work email.
Reframe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2022 | ||||
| Series A | Jan 18, 2022 | ||||
| Seed | Sep 1, 2021 | ||||
| Seed | Aug 1, 2021 | ||||
| Seed | Mar 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reframe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Series A |
| Goodwater Capital | Series A |
| Uncommon Capital | Series A |
| Y Combinator | Series A, Seed |
| Cathexis Ventures | Series A |
| Atlanta Ventures | Series A, Seed |
| HOF Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2025
Introduced 'Super Coaching' with personalized fitness, sleep, nutrition, and mindset support.
- Apr 16, 2025
Surpassed 150,000 paying customers.
For institutional investors. Book with your work email.
Reframe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reframe's valuation, stock price, and market status.
Is Reframe a public or private company?
Reframe is a private company.
What is the current stock price of Reframe?
Reframe is a private company, so its shares have no public market price. Caplight tracks Reframe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reframe worth (valuation)?
Reframe's valuation is estimated at $100.0M based on funding round data.
Can I buy Reframe stock?
Reframe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reframe's last funding round?
Reframe's most recent funding round was Series A on March 5, 2022.
Who are the main investors in Reframe?
Key investors in Reframe include Goodwater Capital, Y Combinator, Atlanta Ventures, CREATE-X.
Will Reframe IPO soon?
No public IPO plans have been announced for Reframe.
How can I track Reframe secondary market activity?
Caplight tracks bids, offers, and trades in Reframe's shares on secondary markets.